Search

FDA Approved Drug for Hepatitis C: New Fixed-Dose Combination - Sofosbuvir, Velpatasvir and Voxilaprevir

FDA APPROVED DRUG FOR HEPATITIS C: NEW FIXED-DOSE COMBINATION - SOFOSBUVIR, VELPATASVIR AND VOXILAPREVIR

The US FDA has approved a fixed-dose combination of sofosbuvir, velpatasvir and voxilaprevir for the treatment of hepatitis C.

 
 
 
New Drug Sofosbuvir can Reduce Transplant and Mortality Rates in Patients With Hepatitis C

NEW DRUG SOFOSBUVIR CAN REDUCE TRANSPLANT AND MORTALITY RATES IN PATIENTS WITH HEPATITIS C

The new drug called sofosbuvir reduced the progression of advanced liver disease in hepatitis C patients. Patients with cirrhosis can...

FDA Approves Drugs for Hepatitis C Infected Older Children

FDA APPROVES DRUGS FOR HEPATITIS C INFECTED OLDER CHILDREN

The US FDA has approved the use of sofosbuvir and sofusbuvir-ledipasvir combination for hepatitis C in children over 12 years of age.